The synergistic increase of ROS levels to cytotoxic lethal levels in response to co-targeting the Trx and GSH systems in GBM cell lines and GSCs might be required to overcome their intrinsic resistance to pro-oxidant strategies. This evidence concerns the gene TXN and glioblastoma.